Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Mineral dust as a driver of carbon accumulation in northern latitudes.

Kylander ME, Martínez-Cortizas A, Bindler R, Kaal J, Sjöström JK, Hansson SV, Silva-Sánchez N, Greenwood SL, Gallagher K, Rydberg J, Mörth CM, Rauch S.

Sci Rep. 2018 May 2;8(1):6876. doi: 10.1038/s41598-018-25162-9.

2.

Slutreplik om AT- och ST-platser i Stockholm: - Det går i alldeles för långsam takt.

Styrud J, Sjöström J.

Lakartidningen. 2017 Jun 22;114. pii: ERPZ. Swedish. No abstract available.

PMID:
28654137
Free Article
3.

Fifteen Challenges in Establishing a Multidisciplinary Research Program on eHealth Research in a University Setting: A Case Study.

Grönqvist H, Olsson EMG, Johansson B, Held C, Sjöström J, Lindahl Norberg A, Hovén E, Sanderman R, van Achterberg T, von Essen L.

J Med Internet Res. 2017 May 23;19(5):e173. doi: 10.2196/jmir.7310.

4.

Is ownership the decisive factor in collaborations between occupational health services and client companies?

Schmidt L, Sjöström J, Antonsson AB.

Work. 2017;56(2):309-318. doi: 10.3233/WOR-172498.

PMID:
28234266
5.

[Time to solve the summer situation in health care].

Sjöström J.

Lakartidningen. 2015 Sep 21;112. pii: DPUY. Swedish. No abstract available.

6.

Betula pendula: A Promising Candidate for Phytoremediation of TCE in Northern Climates.

Lewis J, Qvarfort U, Sjöström J.

Int J Phytoremediation. 2015;17(1-6):9-15. doi: 10.1080/15226514.2013.828012.

PMID:
25174420
7.

The Origin and Impact of Ideals in eHealth Research: Experiences From the U-CARE Research Environment.

Sjöström J, von Essen L, Grönqvist H.

JMIR Res Protoc. 2014 May 23;3(2):e28. doi: 10.2196/resprot.3202.

8.

Successful collaboration between occupational health service providers and client companies: Key factors.

Schmidt L, Sjöström J, Antonsson AB.

Work. 2015 Jun 5;51(2):229-37. doi: 10.3233/WOR-141855.

PMID:
24763348
9.

Long-range diffusion in xylitol-water mixtures.

Elamin K, Cazzato S, Sjöström J, King SM, Swenson J.

J Phys Chem B. 2013 Jun 20;117(24):7363-9. doi: 10.1021/jp401633g. Epub 2013 Jun 10.

PMID:
23697683
10.

The effect of subsurface military detonations on vadose zone hydraulic conductivity, contaminant transport and aquifer recharge.

Lewis J, Burman J, Edlund C, Simonsson L, Berglind R, Leffler P, Qvarfort U, Thiboutot S, Ampleman G, Meuken D, Duvalois W, Martel R, Sjöström J.

J Contam Hydrol. 2013 Mar;146:8-15. doi: 10.1016/j.jconhyd.2012.12.007. Epub 2012 Dec 30.

PMID:
23353636
11.

Calorimetric and relaxation properties of xylitol-water mixtures.

Elamin K, Sjöström J, Jansson H, Swenson J.

J Chem Phys. 2012 Mar 14;136(10):104508. doi: 10.1063/1.3692609.

PMID:
22423849
12.

How can occupational health services in Sweden contribute to work ability?

Schmidt L, Sjöström J, Antonsson AB.

Work. 2012;41 Suppl 1:2998-3001. doi: 10.3233/WOR-2012-0555-2998.

PMID:
22317176
13.

Hydrogen bond induced nonmonotonic composition behavior of the glass transition in aqueous binary mixtures.

Sjöström J, Mattsson J, Bergman R, Swenson J.

J Phys Chem B. 2011 Aug 25;115(33):10013-7. doi: 10.1021/jp2024186. Epub 2011 Aug 2.

PMID:
21749122
14.

Effects of water contamination on the supercooled dynamics of a hydrogen-bonded model glass former.

Sjöström J, Bergman R, Wadell C, Moberg T, Swenson J, Mattsson J.

J Phys Chem B. 2011 Mar 3;115(8):1842-7. doi: 10.1021/jp108070c. Epub 2011 Feb 7.

PMID:
21299230
15.

Reduced mobility of di-propylene glycol methylether in its aqueous mixtures by quasielastic neutron scattering.

Swenson J, Sjöström J, Fernandez-Alonso F.

J Chem Phys. 2010 Dec 21;133(23):234506. doi: 10.1063/1.3515958.

PMID:
21186874
16.

Dielectric secondary relaxation of water in aqueous binary glass-formers.

Sjöström J, Mattsson J, Bergman R, Johansson E, Josefsson K, Svantesson D, Swenson J.

Phys Chem Chem Phys. 2010 Sep 21;12(35):10452-6. doi: 10.1039/c001275k. Epub 2010 Jul 3.

PMID:
20601989
17.

Optimizing the experimental design of soil columns in saturated and unsaturated transport experiments.

Lewis J, Sjöstrom J.

J Contam Hydrol. 2010 Jun 25;115(1-4):1-13. doi: 10.1016/j.jconhyd.2010.04.001. Epub 2010 Apr 14. Review.

PMID:
20452088
18.

Distribution, chemical speciation, and mobility of lead and antimony originating from small arms ammunition in a coarse-grained unsaturated surface sand.

Lewis J, Sjöström J, Skyllberg U, Hägglund L.

J Environ Qual. 2010 Apr 13;39(3):863-70. doi: 10.2134/jeq2009.0211. Print 2010 May-Jun.

PMID:
20400582
19.

Investigating hydration dependence of dynamics of confined water: monolayer, hydration water and Maxwell-Wagner processes.

Sjöström J, Swenson J, Bergman R, Kittaka S.

J Chem Phys. 2008 Apr 21;128(15):154503. doi: 10.1063/1.2902283.

PMID:
18433231
20.
21.

The dynamics of water in hydrated white bread investigated using quasielastic neutron scattering.

Sjöström J, Kargl F, Fernandez-Alonso F, Swenson J.

J Phys Condens Matter. 2007 Oct 17;19(41):415119. doi: 10.1088/0953-8984/19/41/415119.

PMID:
28192331
22.

TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.

Villman K, Sjöström J, Heikkilä R, Hultborn R, Malmström P, Bengtsson NO, Söderberg M, Saksela E, Blomqvist C.

Acta Oncol. 2006;45(5):590-6.

PMID:
16864174
23.

Reswelling of polyelectrolyte hydrogels by oppositely charged surfactants.

Lynch I, Sjöström J, Piculell L.

J Phys Chem B. 2005 Mar 10;109(9):4258-62.

PMID:
16851489
24.

Hydrophobicity and counterion effects on the binding of ionic surfactants to uncharged polymeric hydrogels.

Lynch I, Sjöström J, Piculell L.

J Phys Chem B. 2005 Mar 10;109(9):4252-7.

PMID:
16851488
25.

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer.

Poikonen P, Sjöström J, Amini RM, Villman K, Ahlgren J, Blomqvist C.

Br J Cancer. 2005 Sep 5;93(5):515-9.

26.

Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).

Ejlertsen B, Mouridsen HT, Langkjer ST, Andersen J, Sjöström J, Kjaer M; Scandinavian Breast Group Trial (SBG9403.

J Clin Oncol. 2004 Jun 15;22(12):2313-20.

PMID:
15197192
27.

Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel.

Poikonen P, Sjöström J, Klaar S, Nittby LT, Sigurdsson H, Madsen EL, Joensuu H, Blomqvist C.

Acta Oncol. 2004;43(2):190-5.

PMID:
15163169
28.

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.

Carlsson J, Nordgren H, Sjöström J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C.

Br J Cancer. 2004 Jun 14;90(12):2344-8. Review.

29.

Perceptual matching for assessment of itch; reliability and responsiveness analyzed by a rank-invariant statistical method.

Stener-Victorin E, Lundeberg T, Kowalski J, Opdal L, Sjöström J, Lundeberg L.

J Invest Dermatol. 2003 Dec;121(6):1301-5.

30.

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.

Luoma ML, Hakamies-Blomqvist L, Sjöström J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmström P, Valvere V, Tennvall L, Blomqvist C.

Eur J Cancer. 2003 Jul;39(10):1370-6.

PMID:
12826039
31.

Predictive factors for response to chemotherapy in advanced breast cancer.

Sjöström J.

Acta Oncol. 2002;41(4):334-45. Review.

PMID:
12234024
32.

Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 1.

Kühler TC, Swanson M, Christenson B, Klintenberg AC, Lamm B, Fägerhag J, Gatti R, Olwegård-Halvarsson M, Shcherbuchin V, Elebring T, Sjöström JE.

J Med Chem. 2002 Sep 12;45(19):4282-99.

PMID:
12213070
33.

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.

Tynninen O, Sjöström J, von Boguslawski K, Bengtsson NO, Heikkilä R, Malmström P, Ostenstad B, Wist E, Valvere V, Saksela E, Paavonen T, Blomqvist C.

Br J Cancer. 2002 Jun 17;86(12):1905-8.

34.

Physical performance, toxicity, and quality of life as assessed by the physician and the patient.

Luoma ML, Hakamies-Blomqvist L, Sjöström J, Mouridsen H, Pluzanska A, Malmström P, Bengtsson NO, Hultborn R, Ostenstaad B, Mjaaland I, Valvere V, Wist E, Baldursson G, Ahigren J, Blomqvist C.

Acta Oncol. 2002;41(1):44-9.

PMID:
11990517
35.

The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.

Sjöström J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed JC, Saksela E.

Clin Cancer Res. 2002 Mar;8(3):811-6.

36.

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer.

Sjöström J, Collan J, von Boguslawski K, Franssila K, Bengtsson NO, Mjaaland I, Malmström P, Østenstad B, Wist E, Valvere V, Bergh J, Skiöld-Petterson D, Saksela E, Blomqvist C.

Eur J Cancer. 2002 Mar;38(4):535-42.

PMID:
11872346
37.

Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer.

Sjöström J, Alfthan H, Joensuu H, Stenman UH, Lundin J, Blomqvist C.

Scand J Clin Lab Invest. 2001;61(6):431-41.

PMID:
11681532
38.

Timing of quality of life (QoL) assessments as a source of error in oncological trials.

Hakamies-Blomqvist L, Luoma ML, Sjöström J, Pluzanska A, Sjödin M, Mouridsen H, Østenstad B, Mjaaland I, Ottosson S, Bergh J, Malmström PO, Blomqvist C.

J Adv Nurs. 2001 Sep;35(5):709-16.

PMID:
11529973
39.

How apoptosis is regulated, and what goes wrong in cancer.

Sjöström J, Bergh J.

BMJ. 2001 Jun 23;322(7301):1538-9. Review. No abstract available.

40.

Influence of TNT transformation on microbial community structure in four different lake microcosms.

Wikström P, Andersson AC, Nygren Y, Sjöström J, Forsman M.

J Appl Microbiol. 2000 Aug;89(2):302-8.

41.

Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.

Sjöström J, Blomqvist C, Heikkilä P, Boguslawski KV, Räisänen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E.

Clin Cancer Res. 2000 Aug;6(8):3103-10.

42.

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

Hakamies-Blomqvist L, Luoma M, Sjöström J, Pluzanska A, Sjödin M, Mouridsen H, Ostenstad B, Mjaaland I, Ottosson-Lönn S, Bergh J, Malmström P, Blomqvist C.

Eur J Cancer. 2000 Jul;36(11):1411-7.

PMID:
10899655
43.

Cytostar-T scintillating microplate assay for measurement of sodium-dependent bile acid uptake in transfected HEK-293 cells.

Bonge H, Hallén S, Fryklund J, Sjöström JE.

Anal Biochem. 2000 Jun 15;282(1):94-101.

PMID:
10860504
44.

Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).

Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Sjöström J, Grönlund H, Lernmark A.

Horm Metab Res. 2000 Apr;32(4):133-8.

PMID:
10824708
45.

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

Sjöström J, Blomqvist C, Mouridsen H, Pluzanska A, Ottosson-Lönn S, Bengtsson NO, Ostenstad B, Mjaaland I, Palm-Sjövall M, Wist E, Valvere V, Anderson H, Bergh J.

Eur J Cancer. 1999 Aug;35(8):1194-201.

PMID:
10615229
46.

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

Sjöström J, Krajewski S, Franssila K, Niskanen E, Wasenius VM, Nordling S, Reed JC, Blomqvist C.

Br J Cancer. 1998 Sep;78(6):812-5.

47.

Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.

Kühler TC, Swanson M, Shcherbuchin V, Larsson H, Mellgârd B, Sjöström JE.

J Med Chem. 1998 May 21;41(11):1777-88.

PMID:
9599229
48.

Growth and survival of Helicobacter pylori in defined medium and susceptibility to Brij 78.

Albertson N, Wenngren I, Sjöström JE.

J Clin Microbiol. 1998 May;36(5):1232-5.

49.

Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp.

Sjøstrøm JE, Kühler T, Larsson H.

Antimicrob Agents Chemother. 1997 Aug;41(8):1797-801.

50.

Failed treatment of pseudomyxoma peritonei (PMP) with intraperitoneal interferon alpha.

Maiche AG, Sjöström J.

Eur J Surg Oncol. 1996 Dec;22(6):640. No abstract available.

PMID:
9005155

Supplemental Content

Loading ...
Support Center